Gene · 1366
Papers1,866
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,866
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring therapeutic potential of claudin in Flavivirus infection: A review on current advances and future perspectives. | Int J Biol Macromol | 2025 | 40203926 | PubTator, text mining | PubMed |
An Integrated Approach Utilizing Single-Cell and Bulk RNA-Sequencing for the Identification of a Mitophagy-Associated Genes Signature: Implications for Prognostication and Therapeutic Stratification in Prostate Cancer. | Biomedicines | 2025 | 40002724 | PubTator, text mining | PubMed |
| Effects of small extracellular vesicles derived from normoxia- and hypoxia-treated prostate cancer cells on the submandibular salivary gland epithelium in vitro. | Tissue Barriers | 2025 | 38721756 | PubTator, text mining | PubMed |
| Chromatin accessibility reveals potential prognostic value of the peak set associated with smoking history in patients with lung adenocarcinoma. | Heliyon | 2024 | 39720074 | PubTator, text mining | PubMed |
| Invasive micropapillary carcinoma of the breast and invasive breast carcinoma of no special type: a comparison of claudin proteins' expression and its impact on survival. | Pathol Oncol Res | 2024 | 39687048 | PubTator, text mining | PubMed |
| A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer. | bioRxiv | 2024 | 39677819 | PubTator, text mining | PubMed |
| Apical integrins as a switchable target to regulate the epithelial barrier. | J Cell Sci | 2024 | 39552289 | PubTator, text mining | PubMed |
| Computational insights into irinotecan's interaction with UBE2I in ovarian and endometrial cancers. | Comput Biol Chem | 2024 | 39476484 | PubTator, text mining | PubMed |
| Correction: The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities. | Cell Commun Signal | 2024 | 39402584 | PubTator, text mining | PubMed |
| Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases. | J Hepatocell Carcinoma | 2024 | 39345937 | PubTator, text mining | PubMed |
| Expression Profiles of Claudin Gene Family Members in Patients With Recurrent Calcium Oxalate Kidney Stones. | Cureus | 2024 | 39345805 | PubTator, text mining | PubMed |
| Claudin 7 suppresses invasion and metastasis through repression of a smooth muscle actin program. | J Cell Biol | 2024 | 39320351 | PubTator, text mining | PubMed |
| [Renal eosinophilic vacuolated tumor: a clinicopathological analysis of seven cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39231743 | PubTator, text mining | PubMed |
| The downregulation of tight junction proteins and pIgR in the colonic epithelium causes the susceptibility of EpCAM+/- mice to colitis and gut microbiota dysbiosis. | Front Mol Biosci | 2024 | 39188786 | PubTator, text mining | PubMed |
| Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer. | Diagn Pathol | 2024 | 39175074 | PubTator, text mining | PubMed |
| Absence of claudin-3 does not alter intestinal absorption of phosphate in mice. | Pflugers Arch | 2024 | 39115555 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Permeability is Affected by Changes in Tight Junction Protein Expression at High-Altitude Hypoxic Conditions-this may have Implications for Brain Drug Transport. | AAPS J | 2024 | 39107477 | PubTator, text mining | PubMed |
| Intestinal epithelial Cldn-7 regulates intestinal inflammation by altering the gut microbiota. | Pathol Res Pract | 2024 | 39004000 | PubTator, text mining | PubMed |
| Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer. | J Cell Mol Med | 2024 | 38894657 | PubTator, text mining | PubMed |
| EnsemBic: An effective ensemble of biclustering to identify potential biomarkers of esophageal squamous cell carcinoma. | Comput Biol Chem | 2024 | 38759483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1366/papers?page=3